Suchergebnisse - "Russell, Nigel H"

PubPharm (155)

81

Improving outcomes for elderly patients with AML

enthalten in: The Lancet. Oncology | 2012

von Russell, N.

CommentOn: Lancet Oncol. 2012 Nov;13(11):1096-104. - PMID 23075701

82

Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2012

von Burnett, A. | Russell, N. | Hills, R. | +9

CommentIn: Nat Rev Clin Oncol. 2012 Oct;9(10):551. - PMID 22889971

83

Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia

enthalten in: Journal of clinical oncology / Englische Ausgabe | 2012

von Burnett, A. | Russell, N. | Hills, R. | +9

84

Improving outcomes for elderly patients with AML

enthalten in: The lancet / Oncology | 2012

von Russell, N.

85

Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in Acute Myeloid Leukaemia

enthalten in: BMC cancer | 2012

von Jawad, M. | Yu, N. | Seedhouse, C. | +3

86

Targeting of $ CD34^{+} $$ CD38^{-} $cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia

enthalten in: BMC cancer | 2012

von Jawad, M. | Yu, N. | Seedhouse, C. | +3

87

Targeting of $ CD34^{+} %$ CD38^{-} $cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia

enthalten in: BMC cancer | 2012

von Jawad, M. | Yu, N. | Seedhouse, C. | +3

88

Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission : an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2012

von Nagler, A. | Labopin, M. | Shimoni, A. | +14

89

The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AML

enthalten in: British journal of haematology | 2012

von Burnett, A. | Russell, N. | Culligan, D. | +7

90

The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AML

enthalten in: British journal of haematology | 2012

von Burnett, A. | Russell, N. | Culligan, D. | +6